InvestorsHub Logo
Followers 138
Posts 22909
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Saturday, 10/04/2014 12:05:57 PM

Saturday, October 04, 2014 12:05:57 PM

Post# of 2206
The Use of ddRNAi as a Permanent Gene Silencing Technology for Orphan Diseases – Case Study in OPMD
Confirmed:
Peter French, Chief Executive Officer & Managing Director, Benitec Biopharma Limited, Australia

http://www.giievent.jp/gel296282-2014/catalog.pdf

Good luck and GOD bless,

George
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BNTC News